We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
NEW YORK DAWN™NEW YORK DAWN™NEW YORK DAWN™
Notification Show More
Font ResizerAa
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Reading: Research succeeds in early prognosis of leptomeningeal illness in diffuse midline gliomas by liquid biopsy
Share
Font ResizerAa
NEW YORK DAWN™NEW YORK DAWN™
Search
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Follow US
NEW YORK DAWN™ > Blog > Health > Research succeeds in early prognosis of leptomeningeal illness in diffuse midline gliomas by liquid biopsy
Research succeeds in early prognosis of leptomeningeal illness in diffuse midline gliomas by liquid biopsy
Health

Research succeeds in early prognosis of leptomeningeal illness in diffuse midline gliomas by liquid biopsy

Last updated: January 28, 2025 1:19 pm
Editorial Board Published January 28, 2025
Share
SHARE

A photograph of Natsumeda lab members, together with Dr. Satoshi Shibuma (far left) and Dr. Manabu Natsumeda (far proper). Credit score: Niigata College

A bunch led by the Division of Neurosurgery, Mind Analysis Institute, Niigata College, has succeeded within the prognosis of leptomeningeal illness in diffuse midline gliomas by detecting H3K27M-mutant droplets from circulating tumor DNA of cerebrospinal fluid taken from these sufferers.

The work is printed within the journal Pediatric Blood & Most cancers on January 9, 2025.

In two sufferers, leptomeningeal illness was identified sooner than with conventional strategies reminiscent of MRI and cerebrospinal fluid cytology. In a single affected person, long run survival after the prognosis of leptomeningeal illness by early and aggressive intervention together with surgical procedure, radiation, and intrathecal supply of chemotherapeutic brokers led to long run survival.

A group led by Dr. Manabu Natsumeda used droplet digital PCR, a extremely delicate PCR system, to detect hint quantities of circulating tumor DNA from the cerebrospinal fluid of those sufferers.

“We found that detecting circulating tumor DNA in the cerebrospinal fluid of diffuse midline glioma patients was more difficult than other brain tumor patients such as primary central nervous system lymphoma and glioblastoma,” explains Dr. Natsumeda.

“However, when we were able to detect mutant tumor DNA, often the tumor had already spread to the cerebrospinal fluid, causing leptomeningeal disease. We think that early diagnosis and treatment of leptomeningeal disease in diffuse midline gliomas can improve survival.”

Extra info:
Satoshi Shibuma et al, Analysis of Leptomeningeal Illness in Diffuse Midline Gliomas by Detection of H3F3A K27M Mutation in Circulating Tumor DNA of Cerebrospinal Fluid, Pediatric Blood & Most cancers (2025). DOI: 10.1002/pbc.31535

Offered by
Niigata College

Quotation:
Research succeeds in early prognosis of leptomeningeal illness in diffuse midline gliomas by liquid biopsy (2025, January 27)
retrieved 28 January 2025
from https://medicalxpress.com/information/2025-01-succeeds-early-diagnosis-leptomeningeal-disease.html

This doc is topic to copyright. Aside from any honest dealing for the aim of personal research or analysis, no
half could also be reproduced with out the written permission. The content material is supplied for info functions solely.

You Might Also Like

Genetic mutation linked to iron deficiency in Crohn’s illness sufferers

Deprived backgrounds can depart a lifelong accelerated getting old marker in kids

Weight problems linked to subsequent neoplasms in childhood most cancers survivors

Blood check reveals 95% accuracy for Alzheimer’s illness analysis in outpatient reminiscence clinics

4 states ask FDA to carry guidelines on abortion tablet mifepristone

TAGGED:biopsydiagnosisdiffusediseaseEarlygliomasleptomeningealLiquidmidlinestudysucceeds
Share This Article
Facebook Twitter Email Print

Follow US

Find US on Social Medias
FacebookLike
TwitterFollow
YoutubeSubscribe
TelegramFollow
Popular News
Inspecting NFL Draft historical past to gauge potential Giants commerce worth for No. 1 decide
Sports

Inspecting NFL Draft historical past to gauge potential Giants commerce worth for No. 1 decide

Editorial Board March 6, 2025
Trump strips safety clearance from political foes, together with Tish James, Alvin Bragg
Brett Baty off to a different robust spring begin as he fights to safe position with Mets
Commentary: The Grammys promised to honor L.A. fireplace victims. As a substitute it turned them into props
Here’s How Philadelphia’s Covid Mandate for Health Workers Worked

You Might Also Like

Scientific group urges larger motion towards the silent rise of liver ailments
Health

Scientific group urges larger motion towards the silent rise of liver ailments

June 7, 2025
New guidelines for beauty injectables intention to make the {industry} safer. Will they work?
Health

New guidelines for beauty injectables intention to make the {industry} safer. Will they work?

June 7, 2025
Resident-to-resident aggression is frequent in nursing properties. This is how we are able to enhance residents’ security
Health

Resident-to-resident aggression is frequent in nursing properties. This is how we are able to enhance residents’ security

June 7, 2025
Higher planning can cut back illness absence amongst shift staff
Health

Higher planning can cut back illness absence amongst shift staff

June 7, 2025

Categories

  • Health
  • Sports
  • Politics
  • Entertainment
  • Technology
  • World
  • Art

About US

New York Dawn is a proud and integral publication of the Enspirers News Group, embodying the values of journalistic integrity and excellence.
Company
  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement
Contact Us
  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability
Term of Use
  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© 2024 New York Dawn. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?